Skip to main content
Image
Redefining quantitative train-of-four (TOF) monitoring
How TetraGraph leads the industry

Invented by an anesthesiologist wanting to do better for his patients, Senzime's TetraGraph is backed by clinical research at leading hospitals.

TetraGraph is the most rigorously studied quantitative TOF monitor available, widely used in clinical practice today.

TetraGraph has not only streamlined our anesthesia workflow, but has also elevated the standard of care we provide to our patients.

- Steve Hultgren, Anesthesia Technician Supervisor at CHI Health

Image
Latest @ Senzime Linkedin
 
Our expertise – Your confidence

40

years of research as backbone of products

105

approved patents, and counting

45

clinical studies

3500

installations in operating rooms, and counting
Enhancing your daily practice

Supporting you from start to finish

We provide more than cutting-edge technology. Our commitment extends to helping you excel with resources and support tailored to your needs.

Learn about the latest clinical guidelines, get started with quantitative TOF monitoring, and access valuable insights to improve patient outcomes.

Senaste bloggar
| Blog
Why implement TetraGraph? Hear it from the experts
| Blog
Bridging science and practice: Reflections from the 2025 International Neuromuscular Symposium
| Blog
Why next-generation TetraGraph?
| Blog
The benefits of EMG-based monitoring in robotic-assisted surgeries
Senzime is leading the new standard of care

Senzime is a pioneering medical device company specializing in precision-based patient monitoring systems.

Our mission is to safeguard every patient’s journey, from anesthesia to recovery.